这剧本已经想好了，
前面接受国药跟科兴疫苗的中国人，
接着再打了BNT后，
中国政府会宣称，BNT的效果是建立在国药与科兴疫苗的基础之上。
皆下来就会大量把这成果送到国外去，
然后跟对方说，我的疫苗很有效，但是加上BNT的会更好唷，
BNT请自己去想办法拿～揪瞇。
不过话说，中国不是也有在研究mRNA疫苗？
这时候放行BNT这中间是有什么猫腻？
※ 引述《gibbs1286 (学无止境是国关)》之铭言：
: https://reurl.cc/4a88LV
: 路透社报导
: Fosun-BioNTech COVID-19 vaccine completes China regulator review - media
: SHANGHAI, July 15 (Reuters) - Chinese regulators have completed an expert
: review of a COVID-19 mRNA vaccine developed by Germany's BioNTech (22UAy.DE)
: and Fosun Pharma (600196.SS) and the shot is in the administration review
: stage, Caixin reported, citing the Chinese company.
: China hasn't approved any COVID-19 vaccine developed overseas but
: greenlighted several domestic brands, administering 1.4 billion doses so far,
: or two-fifths of the global total of 3.47 billion doses.
: BioNTech Chief Executive Ugur Sahin said in April he expected its COVID-19
: vaccine would win approval from the Chinese authorities "by June at the
: latest."
: BioNTech and Fosun did not immediately reply to Reuters' requests for comment.
: The vaccine is on track to begin trial production in China at the end of
: August, Caixin cited Fosun Pharma chairman Wu Yifang as saying at a
: shareholders' meeting on Wednesday.
: It said the vaccine would be used as a booster shot for people who have
: received vaccines using inactivated viruses.
: These are vaccines that use a coronavirus that cannot replicate in human
: cells and include Sinovac's (SVA.O) COVID-19 shot.
: 简单来说就是中国政府对BNT疫苗已经通过专家审查，进入行政审查并预计作为那些打过
: 科兴、国药的人的第三针加强剂，然后八月底复星在中国开始试生产BNT疫苗
: 复星：反正你最后都还是要打BNT的，为什么不一开始就打BNT呢，ㄏㄏ
: 好险郭董跟GG已经完成签约了，不然再过几个月复星真的可能不卖台湾了....因为优先供给中国国内
如果是复星在中国国内生产的BNT，那还真的不能进口到台湾。
: 只是这算是侧面说中国国产疫苗算是不成功吗?因为最后还是要打国外的疫苗XD